MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bcr-2019-231725

Медицинская библиотека · BMJ case reports · 2020

Rapid development of severe acute respiratory distress syndrome after abatacept treatment in a patient with rheumatoid arthritis.

Gower Jorge, Labarca Gonzalo, Enos Daniel, Nova-Lamperti Estefania

Клинический случайСтатьяПеревод в очереди

Аннотация

Abatacept is a biological agent that modulates T-cell costimulation by blocking CD28 signalling. This cytotoxic T-lymphocyte-associated antigen-4-Ig fusion protein was approved for treatment of rheumatoid arthritis (RA). However, a few case reports have revealed respiratory failure after abatacept treatment. In this report, we present a patient with RA who developed severe acute respiratory distress syndrome (ARDS) and who passed away 2 months after starting abatacept. A comprehensive analysis including radiology, blood examinations, infectious panel and flow cytometry lymphocyte analysis was done to determine the cause of respiratory failure. Since no infection was detected in this patient, an association between ARDS and abatacept is a strong possibility due to significant adverse reactions to the biological agent. Considering the rapid progression of respiratory failure after abatacept treatment in this report, we suggest that pulmonary function testing and lung structure evaluation be regarded throughout the early stage of treatment of patients with RA.

Для цитирования: Gower Jorge, Labarca Gonzalo, Enos Daniel, Nova-Lamperti Estefania. Rapid development of severe acute respiratory distress syndrome after abatacept treatment in a patient with rheumatoid arthritis.. BMJ case reports. 2020. DOI: 10.1136/bcr-2019-231725.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.